Asset
MONARSEN
BioLineRx Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01506362 | phase2 | completed | 2012-03-01 | 2013-05-01 | BioLineRx, Ltd. | Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis |
FDA applications (0)
This company has no applications containing this asset.